Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic lock solution vs guide-wire exchange for hemodialysis catheter-related bacteremia
NCT02040818Phase 3Withdrawn
- Sponsor
- University of California, San Diego
- Start
- Nov 2013
- Primary completion
- Jan 2017
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of tigecycline, acetylcysteine, heparin in Bacteremia, sponsored by University of California, San Diego. Planned start Nov 2013; status: withdrawn.
02
Drugs
tigecyclineacetylcysteineheparin
03
Conditions
Bacteremia
Beyond the preview
Go deeper on NCT02040818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040818.